Nijjar Simrit, Bottomley Cecilia, Oza Munira, Timor-Tritsch Ilan E, Agten Andrea Kaelin, D'Antonio Francesco, Chong Krystle Y, Vuong Lan N, Li Jin, Acklom Rosanna, Mol Ben W, Jurkovic Davor
EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.
The Ectopic Pregnancy Trust, London, UK.
Trials. 2025 Jun 4;26(1):191. doi: 10.1186/s13063-025-08879-7.
Caesarean scar ectopic pregnancy (CSEP) is the most common of type of uterine ectopic pregnancy and is associated with significant morbidity. Prompt diagnosis and treatment is therefore of paramount importance. Currently there is no universally agreed treatment option for CSEP supported by any national or international society. Studies evaluating CSEP management report many different outcomes and often define and measure success or complications of various treatments in different ways. This variation in reporting of outcomes leads to heterogeneity and an inability to directly, or reliably compare results of studies, leaving the question of what the optimal treatment is unanswered. We aim to develop a minimum set of outcomes that should be reported in all future research in CSEP.
An international steering committee of key stakeholders, including researchers, healthcare professionals, patient advocates, and people with a lived experience of CSEP, has been established. A long list of potential outcomes will be identified from a systematic literature review and by interviewing people with a lived experience of CSEP. Key stakeholders will then be asked to prioritise the outcomes via a modified 2-round Delphi survey. Outcomes will be scored using a modified nine-point Likert scale that ranges from 1 (extremely unimportant) to 9 (extremely important) and an additional outcome of 'I can't rate the outcome because I don't know the outcome'. Finally, the steering group will refine by consensus the final core outcome set. The consensus process will result in a core outcome set that is internationally relevant to all key stakeholders. We will actively disseminate our findings to help improve clinical trials and guidelines with the ultimate aim of improving the diagnosis and management of CSEP.
Implementing a core outcome set for CSEP will prevent research waste and improve patient centredness, by enabling reliable comparisons of different treatments for CSEP. This process will also help raise awareness of this condition, increasing clinician knowledge, which in turn will help them counsel patients more effectively, therefore benefiting professionals and patients alike. Expertise in diagnosing and managing this condition is currently focused in a handful of expert centres and many healthcare professionals are not always confident or comfortable in managing these patients and therefore refer them to other centres, which can be considerable distances from patients' localities. This core outcome set will aim to advance sharing of knowledge and spread expertise in time.
COMET 2903. Registered in November 2023. Available online on: https://www.comet-initiative.org/Studies/Details/2903 .
剖宫产瘢痕部位异位妊娠(CSEP)是最常见的子宫异位妊娠类型,且与严重的发病率相关。因此,及时诊断和治疗至关重要。目前,尚无得到任何国家或国际协会支持的、被普遍认可的CSEP治疗方案。评估CSEP管理的研究报告了许多不同的结果,并且常常以不同方式定义和衡量各种治疗的成功或并发症。结果报告的这种差异导致异质性,无法直接或可靠地比较研究结果,使得最佳治疗方法的问题仍未得到解答。我们旨在制定一套在未来所有CSEP研究中都应报告的最少结果集。
已成立一个由关键利益相关者组成的国际指导委员会,其中包括研究人员、医疗保健专业人员、患者权益倡导者以及有CSEP亲身经历的人。将通过系统的文献综述以及采访有CSEP亲身经历的人来确定一长串潜在结果。然后,将要求关键利益相关者通过两轮修改后的德尔菲调查对这些结果进行优先排序。结果将使用修改后的九点李克特量表进行评分,该量表范围从1(极不重要)到9(极为重要),另外还有一个结果选项为“我不知道该结果,无法对其进行评分”。最后,指导小组将通过共识完善最终的核心结果集。共识过程将产生一个对所有关键利益相关者具有国际相关性的核心结果集。我们将积极传播我们的研究结果,以帮助改进临床试验和指南,最终目的是改善CSEP的诊断和管理。
实施CSEP的核心结果集将通过实现对CSEP不同治疗方法的可靠比较来防止研究浪费,并提高以患者为中心的程度。这一过程还将有助于提高对这种疾病的认识,增加临床医生的知识,这反过来又将帮助他们更有效地为患者提供咨询,从而使专业人员和患者都受益。目前,诊断和管理这种疾病的专业知识集中在少数几个专家中心,许多医疗保健专业人员在管理这些患者时并不总是有信心或感到自在,因此会将他们转诊到其他中心,而这些中心可能离患者所在地相当远。这个核心结果集旨在及时促进知识共享和传播专业知识。
COMET 2903。于2023年11月注册。可在以下网址在线获取:https://www.comet-initiative.org/Studies/Details/2903 。